Diving into hot topics of salivary gland carcinoma management—an EORTC young and early career investigator survey
International guidelines lack strong recommendations in several fields of SGC diagnosis and treatment due to insufficient high-quality data, resulting in heterogeneity in physicians' treatment decision (e.g., adjuvant lymph-node field RT and their low concordance with guidelines, such as the use of concomitant CRT). The survey demonstrated the need for prospective clinical trial data to address these gaps in the future.
Authors
- Daan Nevens (ORCID: https://orcid.org/0000-0002-3881-9199)
- Luigi Lorini (ORCID: https://orcid.org/0000-0001-7557-1017)
- Paolo Bossi (ORCID: https://orcid.org/0000-0003-0135-0224)
- Sara Ronchi (ORCID: https://orcid.org/0000-0002-5518-4121)
- Konrad Klinghammer (ORCID: https://orcid.org/0000-0001-6425-4833)
- Ester M. Orlandi (ORCID: https://orcid.org/0000-0001-6495-8574)
- Petr Szturz
Institutions
- Humanitas University (IT)
- University of Antwerp (BE)
- University of Pavia (IT)
- National Center for Oncological Hadrontherapy (IT)
- Iridium Kankernetwerk (BE)
- IRCCS Humanitas Research Hospital (IT)
- Charité - Universitätsmedizin Berlin (DE)
- University of Lausanne (CH)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-11-08
- DOI
- https://doi.org/10.3389/fonc.2024.1416097
- Citations
- 1
- Primary Topic
- Salivary Gland Tumors Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.57